-
A second human glucagon-like peptide 1 (glp-1) analog/receptor agonist has been approved by the FDA for the treatment of type 2 diabetes mellitus (DM2).
-
About a third of patients with sleep apnea have chronic cough. Such patients are more likely to be women and to have heartburn and rhinitis.
-
Guidelines to assess cardiovascular risk are often inconsistent and poorly developed.
-
The ECG shown above was obtained from a 66-year-old woman with chest discomfort. What is going on in this tracing?
-
The burgeoning population of individuals with type 2 diabetes corresponds to a parallel increase in obesity.
-
Even if asymptomatic, early elective aortic valve replacement should be considered for increasingly symptomatic patients with severe aortic valve stenosis because they have a poor prognosis with a high event rate and a risk of rapid functional deterioration, especially if the peak aortic jet velocity is above 5.5 m/sec.
-
Statins and risk of developing diabetes; Maximize benefits of metform in DM2; Prediabetes therapy and beta-cell function; Onychomycosis: Long-term follow-up; Diagnostic yield of elective coronary angiography; Thyroid hormone analogue for dyslipidemia
-
-
Yellow fever vaccine (YFV) is a live, attenuated viral vaccine that is manufactured using a variety of strains of YF virus. Milder side effects of YFV occur in 2%-10% of people (headache, muscle aches, and fever) within 3 to 9 days of vaccination.
-
Vector-borne diseases remain a danger in the United States, a problem highlighted by recent studies in Arizona and Texas. Reisenman et al detected DNA of Trypanosoma cruzi in 68 of 164 (41.5%) triatomine insects (kissing bugs) collected in Tucson, AZ.